Age and Comorbidities as The Main Factors of Mortality in Covid-19 Patients : A Retrospective Cohort Study
DOI:
https://doi.org/10.18196/ijnp.v7i1.17347Keywords:
age, comorbidities, mortality, COVID-19Abstract
Background: The high mortality rate in COVID-19 patients is associated with demographic factors and comorbid conditions. This is supported by research which shows that a history of comorbidities causes 88% of deaths in SARS-CoV-2 positive patients.Consequently, it is important to identify factors associated with poor outcomes among COVID-19 patients.
Objective: The purpose of this study was to determine the main factors that cause COVID-19 mortality in Indonesia.
Methods: The research design used a retrospective cohort. The population of this study was all Covid-19 patients treated at the 'Aisiyah Ponorogo General Hospital from March to December 2021, totalling 881. The data was arrangedbased on the completeness of the medical records, and seven respondents had to be excluded due to incomplete data. Therefore, the total number of samples used was 874 patients. Data was analyzed using logistic regression.
Result: The multivariate analysis showed that patients aged 46-65 years were 1.45 times greater potential to die than than patients who were 0-25 years old. The risk factors for comorbidities had an effect on the mortality of patients with confirmed cases of COVID-19.The variables that had a significant effect on the mortality of COVID-19 included Diabetes mellitus (OR=1.36), Hypertension (OR = 1.78) and heart disease (OR = 1.4).
Conclusion: The most common causes of mortality in Covid-19 patients are age and comorbidities diseases, there are diabetes mellitus, hypertension and heart disease
References
Bajgain, K. T., Badal, S., Bajgain, B. B., & Santana, M. J. (2021). Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature. American Journal of Infection Control, 49(2), 238–246. https://doi.org/10.1016/j.ajic.2020.06.213
Blagosklonny, M. V. (2020). From causes of aging to death from COVID-19. Aging, 12(11), 10004–10021. https://doi.org/10.18632/aging.103493
Casas-Deza, D., Bernal-Monterde, V., Aranda-Alonso, A. N., Montil-Miguel, E., Julián-Gomara, A. B., Letona-Giménez, L., & Arbones-Mainar, J. M. (2021). Age-related mortality in 61,993 confirmed COVID-19 cases over three epidemic waves in Aragon, Spain. Implications for vaccination programmes. PLOS ONE, 16(12), e0261061. https://doi.org/10.1371/journal.pone.0261061
CDC COVID-19 Response Team. (2020). Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR. Morbidity and Mortality Weekly Report, 69(12), 343–346. https://doi.org/10.15585/mmwr.mm6912e2
Cevik, M., Kuppalli, K., Kindrachuk, J., & Peiris, M. (2020). Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ (Clinical Research Ed.), 371, m3862. https://doi.org/10.1136/bmj.m3862
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X., & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England), 395(10223), 507–513. https://doi.org/10.1016/S0140-6736(20)30211-7
Clark, A., Jit, M., Warren-Gash, C., Guthrie, B., Wang, H. H. X., Mercer, S. W., Sanderson, C., McKee, M., Troeger, C., Ong, K. L., Checchi, F., Perel, P., Joseph, S., Gibbs, H. P., Banerjee, A., Eggo, R. M., & Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group. (2020). Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. The Lancet. Global Health, 8(8), e1003–e1017. https://doi.org/10.1016/S2214-109X(20)30264-3
Djaharuddin, I., Munawwarah, S., Nurulita, A., Ilyas, M., Tabri, N. A., & Lihawa, N. (2021). Comorbidities and mortality in COVID-19 patients. Gaceta Sanitaria, 35, S530–S532. https://doi.org/10.1016/j.gaceta.2021.10.085
Ejaz, H., Alsrhani, A., Zafar, A., Javed, H., Junaid, K., Abdalla, A. E., Abosalif, K. O. A., Ahmed, Z., & Younas, S. (2020). COVID-19 and comorbidities: Deleterious impact on infected patients. Journal of Infection and Public Health, 13(12), 1833–1839. https://doi.org/10.1016/j.jiph.2020.07.014
Gray, W. K., Navaratnam, A. V., Day, J., Wendon, J., & Briggs, T. W. R. (2021). Changes in COVID-19 in-hospital mortality in hospitalised adults in England over the first seven months of the pandemic: An observational study using administrative data. The Lancet Regional Health - Europe, 5, 100104. https://doi.org/10.1016/j.lanepe.2021.100104
Hooper, P. L. (2020). COVID-19 and heme oxygenase: novel insight into the disease and potential therapies. Cell Stress and Chaperones, 25(5), 707–710. https://doi.org/10.1007/s12192-020-01126-9
Indonesian Health Ministry. (2020). 13,2 Persen Pasien COVID-19 Yang Meninggal Memiliki Penyakit Hipertensi. https://www.kemkes.go.id/article/print/20101400002/13-2-persen-pasien-covid-19-yang-meninggal-memiliki-penyakit-hipertensi.html
Kang, S.-J., & Jung, S. I. (2020). Age-Related Morbidity and Mortality among Patients with COVID-19. Infection & Chemotherapy, 52(2), 154. https://doi.org/10.3947/ic.2020.52.2.154
Kementerian Kesehatan RI. (2020). Infodatin tetap produktif, cegah, dan atasi Diabetes Melitus 2020. In Pusat Data dan Informasi Kementerian Kesehatan RI (pp. 1–10).
Li, X., Wang, L., Yan, S., Yang, F., Xiang, L., Zhu, J., Shen, B., & Gong, Z. (2020). Clinical characteristics of 25 death cases with COVID-19: A retrospective review of medical records in a single medical center, Wuhan, China. International Journal of Infectious Diseases, 94, 128–132. https://doi.org/10.1016/j.ijid.2020.03.053
Matla Ilpaj, S., & Nurwati, N. (2020). Analisis Pengaruh Tingkat Kematian Akibat COVID-19 Terhadap Kesehatan Mental Masyarakat di Indonesia. Focus : Jurnal Pekerjaan Sosial, 3(1), 16–28. https://jurnal.unpad.ac.id/focus/article/view/28123
Mishra, P., Parveen, R., Bajpai, R., Samim, M., & Agarwal, N. B. (2021). Impact of cardiovascular diseases on severity of COVID-19 patients: A systematic review. Annals of the Academy of Medicine Singapore, 50(1), 52–60. https://doi.org/10.47102/annals-acadmedsg.2020367
Ni, W., Yang, X., Yang, D., Bao, J., Li, R., Xiao, Y., Hou, C., Wang, H., Liu, J., Yang, D., Xu, Y., Cao, Z., & Gao, Z. (2020). Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Critical Care, 24(1), 1–10. https://doi.org/10.1186/s13054-020-03120-0
Nishiga, M., Wang, D. W., Han, Y., Lewis, D. B., & Wu, J. C. (2020). COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nature Reviews Cardiology, 17(9), 543–558. https://doi.org/10.1038/s41569-020-0413-9
Parasher, A. (2021). COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment. Postgraduate Medical Journal, 97(1147), 312–320. https://doi.org/10.1136/postgradmedj-2020-138577
Perhimpunan Dokter Hipertensi Indonesia. (2021). Konsensus Penatalaksanaan Hipertensi 2021 : Update Konsensus PERHI 2019. Perhimpunan Dokter Hipertensi Indonesia, 1–66.
Rozaliyani, A., Savitri, A. I., Setianingrum, F., Shelly, T. N., Ratnasari, V., Kuswindarti, R., Salama, N., Oktavia, D., Widyastuti, W., & Handayani, D. (2020). Factors Associated with Death in COVID-19 Patients in Jakarta, Indonesia: An Epidemiological Study. Acta Medica Indonesiana, 52(3), 246–254.
Satria, R. M. A., Tutupoho, R. V., & Chalidyanto, D. (2020). Analisis Faktor Risiko Kematian dengan Penyakit Komorbid Covid-19. Jurnal Keperawatan Silampari, 4(1), 48–55. https://doi.org/10.31539/jks.v4i1.1587
WHO. (2020). Coronavirus. https://www.who.int/health-topics/coronavirus#tab=tab_1
WHO. (2022). Indonesia: WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. https://covid19.who.int/region/searo/country/id/
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020). Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, 94, 91–95. https://doi.org/10.1016/j.ijid.2020.03.017
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., & Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England), 395(10229), 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3
Downloads
Additional Files
- Diabetes Mellitus, Hypertension and Heart Disease as Main Comorbid Factors in COVID-19 Patient Mortalityed
- Diabetes Mellitus, Hypertension and Heart Disease as Main Comorbid Factors in COVID-19 Patient Mortalityed
- Diabetes Mellitus, Hypertension and Heart Disease as Main Comorbid Factors in COVID-19 Patient Mortalityed
Published
Issue
Section
License
License
Articles published in the IJNP (Indonesian Journal of Nursing Practices) are licensed under a Attribution 4.0 International (CC BY 4.0) license. You are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
This license is acceptable for Free Cultural Works. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Copyright
Authors who publish with IJNP (Indonesian Journal of Nursing Practices) agree to the following terms:
- Authors retain copyright and grant IJNP (Indonesian Journal of Nursing Practices) the right of first publication with the work simultaneously licensed under an Attribution 4.0 International (CC BY 4.0) that allows others to remix, adapt and build upon the work with an acknowledgment of the work's authorship and of the initial publication in IJNP (Indonesian Journal of Nursing Practices).
- Authors are permitted to copy and redistribute the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in IJNP (Indonesian Journal of Nursing Practices).
